Amniotic fibronectin fragmentation and expression of its domains, sialyl and fucosyl glycotopes associated with pregnancy complicated by intrauterine infection

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 2, 2007, Pages 208-214

  Hirnle, Lidia ^a   Ka̧tnik Prastowska, Iwona ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Amniotic fluid; Fibronectin; Fucosylation; Pregnancy complicated by intrauterine infection; Sialylation

Indexed keywords

FIBRIN; FIBRONECTIN; FUCOSE; LECTIN; MONOCLONAL ANTIBODY; SIALIC ACID DERIVATIVE;

ADULT; AMNION FLUID ANALYSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AMNIOTIC FLUID; FEMALE; FETAL DISEASES; FIBRONECTINS; HUMANS; IMMUNOBLOTTING; INFECTION; PEPTIDE FRAGMENTS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 33847136152     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2007.041     Document Type: Article

References (41)

1. Ffrench-Constant Ch. Alternative splicing of fibronectin - many different proteins but few different functions. Exp Cell Res 1995;21:261-71.
2. Wierzbicka-Patynowski I, Schwarzbauer JE. The ins and outs of fibronectin matrix assembly. J Cell Sci 2003;116:3269-76.
3. Ingham K. http://home.comcast.net/;kennethingham/newsite/index.htm 2006.
4. Yamada K. Fibronectin peptides in cell migration and wound repair. J Clin Invest 2000;105:1507-9.
5. Abe Y, Bui-Thanh NA, Ballantyne CM, Burns AR. Extra domain A and type III connecting segment of fibronectin in assembly and cleavage. Biochim Biophys Res Commun 2005;338:1640-7.
6. Cukierman E, Pankov R, Yamada KM. Cell interactions with three-dimensional matrices. Curr Opin Cell Biol 2002;14:633-9.
7. Hynes RO. The dynamic dialogue between wells and matrices: implications of fibronectin's elasticity. Proc Natl Acad Sci USA 1999;96:2588-90.
8. Tajiri M, Yoshida S, Wada Y. Differential analysis of sitespecific glycans on plasma and cellular fibronectins: application of a hydrophilic affinity method for glycopeptide enrichment. Glycobiology 2005;15:1332-40.
9. Zhu BC, Fisher SF, Pande H, Calaycay J, Shively JE, Laine RA: Human placental (fetal) fibronectin: increased glycosylation and higher protease resistance than plasma fibronectin. Presence of polylactoamine glycopeptides and properties of a 44-kilodalton chymotryptic collagen-binding domain: difference from human plasma fibronectin. J Biol Chem 1984;259:3962-70.
10. Krusius T, Fukuda M, Dell A, Ruoslahti E. Structure of the carbohydrate units of human amniotic fluid fibronectin. J Biol Chem 1985;260:4110-6.
11. Hampel DJ, Köttgen B, Dudenhausen JW, Köttgen E. Fetal fibronectin as a marker for an imminent (preterm) delivery. A new technique using the glycoprotein lectin immunosorbent assay. J Immunol Methods 1999;224:31-42.
12. Fukuda M, Levery SB, Hakomori S. Carbohydrate structure of hamster plasma fibronectin. Evidence for chemical diversity between cellular and plasma fibronectins. J Biol Chem 1982;257:6856-60.
13. Takamoto M, Endo T, Isemura M, Kochibe N, Kobata A. Structure of asparagine-linked oligosaccharides of human placental fibronectin. J Biochem 1989;105:742-50.
14. Köttgen E, Hell B, Müller C, Kainer F, Tauber R. Developmental changes in the glycosylation and binding properties of human fibronectins. Characterization of glycan structures and ligand binding of human fibronectins from adult plasma, cord blood and amniotic fluid. Biol Chem Hoppe-Seyler 1989;370:1285-94.
15. Yi M, Ruoslahti E. Fibronectin fragment inhibits tumor growth, angiogenesis, and metastasis. Proc Natl Acad Sci USA 2001;98:620-4.
16. Barilla ML, Carsons SE. Fibronectin fragments and their role in inflammatory arthritis; Semin Arthritis Rheum 2000;29:252-65.
17. Huynh QN, Wang S, Tafolla E, Gansky SA, Kapila S, Armitage GC, et al. Specific fibronectin fragments of periodontal disease status. J Peridontol 2002;73:1101-10.
18. Magnusson MK, Mosher DF. Fibronectin, structure, assembly and cardiovascular implications. Arterioscler Thromb Vasc Biol 1998;18:1363-70.
19. Ka̧tnik-Prastowska I, Przybysz M, Chełmońska-Soyta A. Fibronectin fragments in human seminal plasma. Acta Biochem Polon 2005;52:557-60.
20. Ka̧tnik-Prastowska I, Kratz ME, Faundez R, Chełmoń ska-Soyta A. Lower expression of α2,3- sialylated fibronectin glycoform and appearance of asialo-fibronectin glycoform are associated with high concentrations of fibronectin in human seminal plasma with abnormal semen parameters. Clin Chem Lab Med 2006;44:1119-25.
21. Linnala A, Von Koskull H, Virtanen I. Isoforms of cellular fibronectin and tenascin in amniotic fluid. FEBS Lett 1994;337:167-70.
22. Hirnle L, Ka̧tnik-Prastowska I. EDA fibronectin isoform of amniotic fluid in relation to normal pregnancy stages and to pregnancies complicated by fetal postmaturity syndrome. Acta Obstet Gyn Scand. Submitted for publication.
23. Faron G, Boulvain M, Irion O, Bernard P-M, Fraser WD. Prediction of preterm delivery by fetal fibronectin: a meta-analysis. Obstet Gynecol 1998;92:153-8.
24. Leitich H, Egarter C, Kaider A, Hohlagschwandtner M, Berghammer P, Husslein P. Cervicovaginal fetal fibronectin as a marker for preterm delivery. Ameta-analysis. Am J Obstet Gynecol 1998;180:1169-76.
25. Yoon BH, Romero R, Moon JB, Oh S-Y, Han S-Y, Kim JC, et al. The frequency and clinical significance of intraamniotic inflammation in patients with a positive cervical fetal fibronectin. Am J Obstet Gynecol 2001;185:1137-42.
26. Goffeng AR, Milsom I, Lindstedt G, ArneLundberg P, Andersch B. Fetal fibronectin in vaginal fluid of women in prolonged pregnancy. Gynecol Obstet Invest 1997;44:224-8.
27. Andrews WW, Goldenberg RL, Hauth JC. Preterm labour: emerging role of genital tract infections. Infect Agent Dis 1995;4:196-211.
28. Jacobsson B. Intra-amniotic infection and inflammation in preterm birth - is bacteria always the connection? Pediatr Res 2005;57:473-4.
29. Maxwell NC, Davies PL, Kotecha S. Antenatal infection and inflammation: what's new? Curr Opin Infect Inflamm 2006;19:253-8.
30. Romero R, Chaiworapongsa T, Espinoza J. Micronutrients and intrauterine infection, preterm birth and fetal inflammatory response syndrome. J Nutr 2003;133:1668S-73.
31. Ghezzi F, Franchi M, Raio L, Di Naro E, Bossi G, D'Eril GV, et al. Elevated amniotic fluid C-reactive protein at the time of genitic amniocentesis is a marker for preterm delivery. Am J Obstet Gynecol 2002;186:268-73.
32. Holst RM, Mattsby-Baltzer I, Wennerholm UB, Hagberg H, Jacobsson B. Interleukin-6 and interleukin-8 in cervical fluid in a population of Swedish women in preterm labor: relationship to microbial invasion of amniotic fluid, intra-amniotic inflammation, and preterm delivery. Acta Obstet Gynecol Scand 2005;84:551-7.
33. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
34. Knibbs R, Goldstein IJ, Ratcliff RM, Shibuya N. Characterization of the carbohydrate binding specificity of the leukoagglutinating lectin from Maackia amurensis. Comparison with other sialic acid-specific lectins. J Biol Chem 1991;266:83-8.
35. Shibuya N, Goldstein IJ, Broekaert WF, Nsimba-Lubaki M, Peeters B, Peumans WJ. The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(α2,6)Gal/GalNAc sequence. J Biol Chem 1987;262:1596-601.
36. Yamashita K, Kochibe N, Ohkura T, Ueda I, Kobata A. Fractionation of L-fucose-containing oligosaccharides on immobilized Aleuria aurantia lectin. J Biol Chem 1985;260:4688-93.
37. Yan L, Wilkins PP, Alvarez-Manilla G, Do SI, Smith DF, Cummings RD. Immobilized Lotus tetragonolobus agglutinin binds oligosaccharides containing the Le(x) determinant. Glycoconjugate J 1997;14:45-55.
38. Audette GF, Vandonselaar M, Delbaere LT. The 2.2 Å resolution structure of the O(H) blood-group-specific lectin I from Ulex europaeus. J Mol Biol 2000;304:423-33.
39. Ka̧tnik I, Jadach J, Krotkiewski H, Gerber J. Investigating the glycosylation of normal and ovarian cancer haptoglobins using digoxigenin-labeled lectins. Glycosyl Dis 1994;1:97-104.
40. Athayde N, Romero R, Maymon E, Gomez R, Pacora P, Yoon BH, et al. Interleukin 16 in pregnancy, parturition, rupture of fetal membranes, and microbial invasion of the amniotic cavity. Am J Obstet Gynecol 2000;182:135-41.
41. Orczyk-Pawiłowicz M, Floriański J, Zalewski J, Ka̧tnik-Prastowska I. Relative amounts of sialic acid and fucose of amniotic fluid glycoconjugates in relation to pregnancy age. Glycoconjugate J 2005;22:433-42.